Transplacental Exposure to Ethylnitrosourea and its Effects on Body, Brain, and Cerebellar Development in the Rat

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effect of transplacental exposure to N-ethyl-N-nitro-sourea (ENU) on body, brain, and cerebellar development was studied in rats. Female Sprague-Dawley albino rats received i.p. injections (15,60,100, or 150 mg/kg) of ENU on the 18th day of gestation. Mothers receiving 60 mg/kg or greater had a decreased litter size and offspring with a high incidence of mortality. ENU treatment had a pronounced effect on prenatal development, and alterations in preweaning body and brain growth were also observed. Offspring subjected to injections of ENU (60,100, and 150 mg/kg, respectively) were the most severely affected, with reductions in body weight (15, 31, and 30%, respectively), brain weight (7, 36, and 29%, respectively), and cerebral width (4,10, and 11%, respectively) recorded at weaning (Day 21). Neonatal brain:body weight ratios showed that ENU caused greater changes in fetal neuroontogeny than in somatic development; however, ratios were similar for experimental and control pups for the remainder of the preweaning period. Cerebellar weight gain in ENUtreated pups differed from that of controls during postnatal development, but only rats treated at a dose of 60 mg/kg experienced significant cerebellar weight reduction (12%) at Day 21. Measurements of cerebellar width showed differences between control and ENU pups from birth to Day 21, and at weaning offspring treated with 15,60,100, and 150 mg/kg, respectively, had deficits of 6,8,12, and 14%, respectively. Cerebellar:brain weight ratios indicated that the brain was often more affected by ENU than was the cerebellum. These results suggest that maternal exposure to ENU retards fetal and postnatal somatic growth and affects perinatal brain and cerebellar development.

Original languageEnglish (US)
Pages (from-to)1263-1268
Number of pages6
JournalCancer Research
Volume38
Issue number5
StatePublished - Jan 1 1978

Fingerprint

Maternal-Fetal Exchange
Ethylnitrosourea
Brain
Weaning
Body Weight
Maternal Exposure
Weights and Measures
Litter Size
Injections
Growth
Cerebellum
Weight Gain
Sprague Dawley Rats
Weight Loss
Parturition
Pregnancy
Mortality

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{0f74e084fef547efacff0f2a5dd25083,
title = "Transplacental Exposure to Ethylnitrosourea and its Effects on Body, Brain, and Cerebellar Development in the Rat",
abstract = "The effect of transplacental exposure to N-ethyl-N-nitro-sourea (ENU) on body, brain, and cerebellar development was studied in rats. Female Sprague-Dawley albino rats received i.p. injections (15,60,100, or 150 mg/kg) of ENU on the 18th day of gestation. Mothers receiving 60 mg/kg or greater had a decreased litter size and offspring with a high incidence of mortality. ENU treatment had a pronounced effect on prenatal development, and alterations in preweaning body and brain growth were also observed. Offspring subjected to injections of ENU (60,100, and 150 mg/kg, respectively) were the most severely affected, with reductions in body weight (15, 31, and 30{\%}, respectively), brain weight (7, 36, and 29{\%}, respectively), and cerebral width (4,10, and 11{\%}, respectively) recorded at weaning (Day 21). Neonatal brain:body weight ratios showed that ENU caused greater changes in fetal neuroontogeny than in somatic development; however, ratios were similar for experimental and control pups for the remainder of the preweaning period. Cerebellar weight gain in ENUtreated pups differed from that of controls during postnatal development, but only rats treated at a dose of 60 mg/kg experienced significant cerebellar weight reduction (12{\%}) at Day 21. Measurements of cerebellar width showed differences between control and ENU pups from birth to Day 21, and at weaning offspring treated with 15,60,100, and 150 mg/kg, respectively, had deficits of 6,8,12, and 14{\%}, respectively. Cerebellar:brain weight ratios indicated that the brain was often more affected by ENU than was the cerebellum. These results suggest that maternal exposure to ENU retards fetal and postnatal somatic growth and affects perinatal brain and cerebellar development.",
author = "Ian Zagon and Patricia McLaughlin",
year = "1978",
month = "1",
day = "1",
language = "English (US)",
volume = "38",
pages = "1263--1268",
journal = "Cancer Research",
issn = "0008-5472",
number = "5",

}

TY - JOUR

T1 - Transplacental Exposure to Ethylnitrosourea and its Effects on Body, Brain, and Cerebellar Development in the Rat

AU - Zagon, Ian

AU - McLaughlin, Patricia

PY - 1978/1/1

Y1 - 1978/1/1

N2 - The effect of transplacental exposure to N-ethyl-N-nitro-sourea (ENU) on body, brain, and cerebellar development was studied in rats. Female Sprague-Dawley albino rats received i.p. injections (15,60,100, or 150 mg/kg) of ENU on the 18th day of gestation. Mothers receiving 60 mg/kg or greater had a decreased litter size and offspring with a high incidence of mortality. ENU treatment had a pronounced effect on prenatal development, and alterations in preweaning body and brain growth were also observed. Offspring subjected to injections of ENU (60,100, and 150 mg/kg, respectively) were the most severely affected, with reductions in body weight (15, 31, and 30%, respectively), brain weight (7, 36, and 29%, respectively), and cerebral width (4,10, and 11%, respectively) recorded at weaning (Day 21). Neonatal brain:body weight ratios showed that ENU caused greater changes in fetal neuroontogeny than in somatic development; however, ratios were similar for experimental and control pups for the remainder of the preweaning period. Cerebellar weight gain in ENUtreated pups differed from that of controls during postnatal development, but only rats treated at a dose of 60 mg/kg experienced significant cerebellar weight reduction (12%) at Day 21. Measurements of cerebellar width showed differences between control and ENU pups from birth to Day 21, and at weaning offspring treated with 15,60,100, and 150 mg/kg, respectively, had deficits of 6,8,12, and 14%, respectively. Cerebellar:brain weight ratios indicated that the brain was often more affected by ENU than was the cerebellum. These results suggest that maternal exposure to ENU retards fetal and postnatal somatic growth and affects perinatal brain and cerebellar development.

AB - The effect of transplacental exposure to N-ethyl-N-nitro-sourea (ENU) on body, brain, and cerebellar development was studied in rats. Female Sprague-Dawley albino rats received i.p. injections (15,60,100, or 150 mg/kg) of ENU on the 18th day of gestation. Mothers receiving 60 mg/kg or greater had a decreased litter size and offspring with a high incidence of mortality. ENU treatment had a pronounced effect on prenatal development, and alterations in preweaning body and brain growth were also observed. Offspring subjected to injections of ENU (60,100, and 150 mg/kg, respectively) were the most severely affected, with reductions in body weight (15, 31, and 30%, respectively), brain weight (7, 36, and 29%, respectively), and cerebral width (4,10, and 11%, respectively) recorded at weaning (Day 21). Neonatal brain:body weight ratios showed that ENU caused greater changes in fetal neuroontogeny than in somatic development; however, ratios were similar for experimental and control pups for the remainder of the preweaning period. Cerebellar weight gain in ENUtreated pups differed from that of controls during postnatal development, but only rats treated at a dose of 60 mg/kg experienced significant cerebellar weight reduction (12%) at Day 21. Measurements of cerebellar width showed differences between control and ENU pups from birth to Day 21, and at weaning offspring treated with 15,60,100, and 150 mg/kg, respectively, had deficits of 6,8,12, and 14%, respectively. Cerebellar:brain weight ratios indicated that the brain was often more affected by ENU than was the cerebellum. These results suggest that maternal exposure to ENU retards fetal and postnatal somatic growth and affects perinatal brain and cerebellar development.

UR - http://www.scopus.com/inward/record.url?scp=0018199996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018199996&partnerID=8YFLogxK

M3 - Article

C2 - 639060

AN - SCOPUS:0018199996

VL - 38

SP - 1263

EP - 1268

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 5

ER -